Taiyen Biotech CoTPE:1737 83 Market Cap is NT$6,380 Mil as of Jul. 10, 2026. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 2,041 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 59.48% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Taiyen Biotech Co's share price for the quarter that ended in Dec. 2025 was NT$31.7. Taiyen Biotech Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 200 Mil. Therefore, Taiyen Biotech Co's market cap for the quarter that ended in Dec. 2025 was NT$6,340 Mil.
Taiyen Biotech Co's quarterly market cap
declined
from Jun. 2025 (NT$6,570 Mil) to Sep. 2025 (NT$6,460 Mil) and
declined
from Sep. 2025 (NT$6,460 Mil) to Dec. 2025 (NT$6,340 Mil).
Taiyen Biotech Co's annual market cap
declined
from Dec. 2023 (NT$6,840 Mil) to Dec. 2024 (NT$6,490 Mil) and
declined
from Dec. 2024 (NT$6,490 Mil) to Dec. 2025 (NT$6,340 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Taiyen Biotech Co's Enterprise Value for Today is NT$4,857 Mil.
Taiyen Biotech Co (TPE:1737) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Taiyen Biotech Co Market Cap Related Terms
Taiyen Biotech Co Market Cap Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Taiyen Biotech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Taiyen Biotech Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiyen Biotech Co (TPE:1737) has a Market Cap of NT$6,380 Mil as of Jul. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Taiyen Biotech Co and its competitors. According to the industry distribution chart, Taiyen Biotech Co ranks #827 out of 2041 companies in the Consumer Packaged Goods industry, placing it in the top 40.5%.
Is Taiyen Biotech Co's Market Cap too high?
Taiyen Biotech Co's current Market Cap is NT$6,380 Mil. Based on the distribution chart, Taiyen Biotech Co ranks #827 out of 2041 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Market Cap compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #827 out of 2041 companies for Market Cap. This puts Taiyen Biotech Co in the upper half of its industry. The industry median Market Cap is 102.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 102.33, based on 2,041 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 102.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current Market Cap is NT$6,380 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current Market Cap is NT$6,380 Mil. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Market Cap is NT$6,380 Mil as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
Market Cap: NT$6,380 Mil
GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
